Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Masahiro Hirakawa"'
Autor:
Kazuyuki Murase, Takayuki Nobuoka, Kohichi Takada, Masahiro Hirakawa, Koji Miyanishi, Chisa Fujita, Tadashi Hasegawa, Hiroyuki Ohnuma, Miyako Mizukami, Naotaka Hayasaka, Ichiro Takemasa, Masanori Sato, Masayoshi Kobune, Akihiro Sakurai, Shintaro Sugita, Junji Kato, Aki Ishikawa
Publikováno v:
World Journal of Gastroenterology
Background Hereditary diffuse gastric cancer (HDGC) is a familial cancer syndrome often associated with germline mutations in the CDH1 gene. However, the frequency of CDH1 mutations is low in patients with HDGC in East Asian countries. Herein, we rep
Autor:
Akira Fukuya, Yasuo Takahashi, Masahiro Hirakawa, Yasushi Sato, Hiroshi Miyamoto, Kyoko Hamaguchi, Tetsuji Takayama, Naoki Muguruma, Tamotsu Sagawa, Koshi Fujikawa, Koichi Okamoto
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
The primary tumour location is an important prognostic factor for previously untreated metastatic colorectal cancer (mCRC). However, the predictive efficacies of primary tumour location, early tumour shrinkage (ETS), and depth of response (DpR) on mC
Autor:
Masahiro Hirakawa, Jun Kawamata, Junji Kato, Ikkei Ohhashi, Akihiro Matsumura, Rei Miyanaga, Shin Hisahara, Daisuke Yamamoto, Katsumasa Tanimoto, Shun Shimohama, Syuuichirou Suzuki
Publikováno v:
Internal Medicine
We herein report a patient with Wernicke-Korsakoff syndrome (WKS) who had neither a history of alcoholism or of history of gastric surgery. A 56-year-old woman was transferred to our hospital because of the loss of consciousness and she was diagnosed
Autor:
Koichi Okamoto, Ichiro Takemasa, Yasushi Sato, Tamotsu Sagawa, Takayuki Nobuoka, Tetsuji Takayama, Koshi Fujikawa, Hiroshi Miyamoto, Masahiro Hirakawa, Hiroyuki Ohnuma, Kyoko Hamaguchi, Yasuo Takahashi, Naoki Muguruma
Publikováno v:
Cancer Chemotherapy and Pharmacology. 83:161-167
The aim of this study was to determine the recommended dose (RD) for a docetaxel/oxaliplatin/S-1 (DOS) regimen in patients with unresectable gastric cancer and to preliminarily evaluate its efficacy. Previously untreated patients with histologically
Autor:
Kazuyuki Murase, Naotaka Hayasaka, Masahiro Hirakawa, Koji Miyanishi, Hiroyuki Ohnuma, Kohichi Takada, Masayoshi Kobune, Junji Kato, Takayuki Nobuoka, Rie Ishizuka, Ichiro Takemasa, Tatsuya Ito, Masanori Sato
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2019 (2019)
Case Reports in Medicine, Vol 2019 (2019)
A 62-year-old Japanese female was referred to our hospital with gastrointestinal bleeding. Although small-bowel bleeding was suspected, no bleeding source was identified by enhanced computed tomography (CT), video capsule endoscopy (VCE), and double-
Autor:
Tamotsu Sagawa, Masahiro Hirakawa, Koji Miyanishi, Motoh Ohi, Yasushi Sato, Teppei Matsuno, Chisa Fujita, Koshi Fujikawa, Tatsuya Ito, Masanori Sato, Masayoshi Kobune, Takayuki Nobuoka, Ichiro Takemasa, Yutaka Okagawa, Michiaki Hirayama, Hiroyuki Ohnuma, Takahiro Osuga, Yasushi Tsuji, Junji Kato, Naotaka Hayasaka
Publikováno v:
Cancer Science
Cisplatin plus 5‐fluorouracil is regarded as standard neoadjuvant chemotherapy for esophageal squamous cell carcinoma (ESCC) in Japan, but the prognosis remains poor. We have previously described how definitive chemoradiotherapy with docetaxel, ned
Autor:
Ichiro Takemasa, Tetsuji Takayama, Koichi Okamoto, Masahiro Hirakawa, Junji Kato, Tetsuro Okamoto, Hiroshi Miyamoto, Naoki Muguruma, Minoru Takahashi, Hiroyuki Ohnuma, Tomohisa Furuhata, Yasushi Sato
Publikováno v:
Cancer Chemotherapy and Pharmacology. 80:1133-1139
The addition of cetuximab to triplet chemotherapy can increase treatment efficacy for patients with metastatic colorectal cancer (mCRC). We explored the dose-limiting toxicity and feasibility of a triweekly capecitabine, oxaliplatin, irinotecan, plus
Autor:
Ichiro Takemasa, Hiroyuki Ohnuma, Tetsuji Takayama, Tamotsu Sagawa, Hiroshi Miyamoto, Takayuki Nobuoka, Mitsuo Shimada, Yasuo Takahashi, Koshi Fujikawa, Minoru Takahashi, Shinich Katsuki, Masahiro Hirakawa, Junji Kato, Yutaka Okagawa, Koichi Okamoto, Yasushi Sato, Syouhei Kikuch, Minami Shinya, Uemura Naoki, Masahiro Maeda
Publikováno v:
Gastric Cancer. 20:517-526
Conversion therapy is an option for unresectable metastatic gastric cancer when distant metastases are controlled by chemotherapy; however, the feasibility and efficacy remain unclear. This study aimed to assess the feasibility and efficacy of conver
Autor:
Masakazu Hori, Masahiro Hirakawa, Koh-ichi Sakata, Koji Miyanishi, Junji Kato, Tamotsu Sagawa, Tsuyoshi Hayashi, Yutaka Okagawa, Takahiro Osuga, Rishu Takimoto, Tsutomu Sato, Yasushi Sato, Masayoshi Kobune, Tetsuji Takayama, Masanori Someya, Kensei Nakata, Hiroyuki Ohnuma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:382-390
Purpose Patient survival in esophageal cancer (EC) remains poor. The purpose of this study was to investigate a regimen of definitive chemoradiation therapy (CRT) that exerts good local control of EC. We performed a phase 1/2 study to assess the safe
Autor:
Koshi Fujikawa, Tamotsu Sagawa, Yasuo Takahashi, Masahiro Hirakawa, Hiroyuki Nagashima, Eriko Waga
Publikováno v:
Gastroenterology. 158:S-1307